The flu vaccine and Sanofi’s Doliprane, unexpected winners of the Covid
Sanofi’s Covid vaccine is not for now. the French pharmaceutical giant is still awaiting the results of its latest clinical trial (phase 3), planned during the first quarter of 2022, to request a possible marketing authorization from the health authorities of the various countries. Read also: Covid-19. New delay for the French Sanofi vaccine: will … Read more